Suppr超能文献

一种超强促黑素肽与太阳紫外线辐射联合作用对人类志愿者皮肤晒黑的影响。

Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers.

作者信息

Dorr Robert T, Ertl Gregory, Levine Norman, Brooks Chris, Bangert Jerry L, Powell Marianne Broome, Humphrey Stuart, Alberts David S

机构信息

Department of Medicine, Cancer Center Division, University of Arizona, Tucson, AZ, USA.

出版信息

Arch Dermatol. 2004 Jul;140(7):827-35. doi: 10.1001/archderm.140.7.827.

Abstract

OBJECTIVE

Three phase 1 clinical trials of a superpotent melanotropic peptide, melanotan-1 (MT-1, or [Nle(4)-D-Phe(7)]alpha-melanocyte-stimulating hormone) were performed to demonstrate safety for MT-1 therapy combined with UV-B light or sunlight.

DESIGN

Open-label studies at 2 dose levels of MT-1 combined with small doses of UV-B to the neck or buttock or full sunlight to half of the back.

SETTING

Dermatology clinics at the Arizona Health Sciences Center, Tucson.

INTERVENTIONS

The first study randomized 4 subjects to MT-1 (0.08 mg/kg per day subcutaneously) and 4 subjects to injections of isotonic sodium chloride (9%) solution for 10 days, followed by neck irradiation with 3 times the minimal erythema dose (MED) of UV-B light. In the next study (n = 12), the MT-1 dosage was increased to 0.16 mg/kg per day for 10 days, with UV-B radiation (0.25-0.75 MED) given to a buttock site for 5 days during (n = 7) or after (n = 5) MT-1 administration. A final study randomized 8 subjects to 3 to 5 days of sunlight to half of the back or to sunlight plus 0.16 mg/kg of MT-1 for 5 days per week for 4 weeks.

RESULTS

Tanning in the first study was achieved in 3 of 4 subjects receiving MT-1, and these subjects also had 47% fewer sunburn cells at the irradiated neck site. More skin sites darkened with the higher dose of MT-1 in the second study. In the third study, there was significantly enhanced tanning of the back in the MT-1 group, and this was maintained at least 3 weeks longer than the tanning in the sunlight-only controls, who required 50% more sun-exposure time for equivalent tanning.

MAIN OUTCOME MEASURE

There were no pathologic findings at any UV-B or sun-exposed sites in any subject. Toxic effects due to MT-1 were minor, consisting of nausea and transient facial flushing.

CONCLUSION

Melanotan-1 can be safely combined with UV-B light or sunlight and appears to act synergistically in the tanning response to light.

摘要

目的

开展一项关于超强促黑素肽——黑素otan-1(MT-1,即[Nle(4)-D-Phe(7)]α-黑素细胞刺激素)的三项1期临床试验,以证明MT-1疗法联合UV-B光或阳光照射的安全性。

设计

在2个剂量水平下进行开放标签研究,将MT-1与小剂量UV-B照射颈部或臀部,或让背部一半接受全日照相结合。

地点

图森市亚利桑那健康科学中心的皮肤科诊所。

干预措施

第一项研究将4名受试者随机分为接受MT-1(每天皮下注射0.08mg/kg)组和4名接受等渗氯化钠(9%)溶液注射组,为期10天,随后对颈部进行3倍最小红斑量(MED)的UV-B光照射。在第二项研究中(n = 12),MT-1剂量增加至每天0.16mg/kg,为期10天,在MT-1给药期间(n = 7)或之后(n = 5),对臀部进行5天的UV-B辐射(0.25 - 0.75MED)。最后一项研究将8名受试者随机分为两组,一组让背部一半接受3至5天阳光照射,另一组让背部一半接受阳光照射加每周5天、为期4周、每天0.16mg/kg的MT-1注射。

结果

在第一项研究中,4名接受MT-1的受试者中有3名实现了晒黑,且这些受试者在照射的颈部部位晒伤细胞减少了47%。在第二项研究中,更高剂量的MT-1使更多皮肤部位变黑。在第三项研究中,MT-1组背部的晒黑明显增强,且这种晒黑效果比仅接受阳光照射的对照组维持时间至少长3周,对照组达到同等晒黑效果所需的日照时间多50%。

主要观察指标

任何受试者在任何UV-B或阳光照射部位均未发现病理改变。MT-1引起的毒性作用较小,包括恶心和短暂的面部潮红。

结论

黑素otan-1可安全地与UV-B光或阳光联合使用,且在对光的晒黑反应中似乎具有协同作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验